Researchers reported on the final results of the RETRO trial, which was conducted to investigate the tapering and withdrawal of DMARDs in patients with RA in stable remission.
Researchers assessed the association between traditional cardiovascular risk factors and disease activity in patients with axial spondyloarthritis.
The American College of Rheumatology shows support for a decision by the Centers for Medicare and Medicaid Services to withdraw a rule implementing “Most Favored Nation” payment model for Part B drugs.
The objective of the study was to determine the risk of developing psoriatic arthritis in patients with psoriasis receiving certain treatments, such as biologics.
The objective of the study was to evaluate the trends for hospitalizations and inpatient mortality from acute myocardial infarction among patients with psoriatic arthritis.
Researchers evaluated the presence of imaging features and clinical signs of disease in healthy first-degree relatives of patients with spondyloarthritis.
Researchers assessed the risk for major adverse cardiovascular events in patients with psoriatic arthritis receiving treatment with different classes of DMARDs.
A case study of a patient who developed an acute gout flare of bilateral first metatarsophalangeal joints after initiating treatment with ibrutinib for chronic lymphocytic leukemia.
Researchers evaluated the efficacy of guselkumab in patients with psoriatic arthritis with imaging-confirmed sacroiliitis consistent with axial involvement.
Researchers evaluated the association between Assessment of Spondyloarthritis International Society Health Index (ASAS-HI) and disease activity and burden in patients with spondyloarthritis.
